Preexisting Antibodies to Platelet Factor 4-Heparin Complexes in Patients with Acute Coronary Syndrome Who Have No History of Heparin Exposure

Publisher： Karger

E-ISSN： 1424-8840|34|1|18-22

ISSN： 1424-8832

Source： Pathophysiology of Haemostasis and Thrombosis, Vol.34, Iss.1, 2005-11, pp. : 18-22

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Heparin enhances uptake of platelet factor 4/heparin complexes by monocytes and macrophages

By  

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 13, Iss. 8, 2015-08 ,pp. : 1416-1427

John Wiley & Sons Inc

Access to resources Recommend Favorite

A prospective study measuring the development of antibodies against platelet factor 4–heparin in healthy males after exposure to heparins

By  

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 10, Iss. 7, 2012-07 ,pp. : 1446-1449

John Wiley & Sons Inc

Access to resources Recommend Favorite

Complexes of platelet factor 4 and heparin activate Toll‐like receptor 4

By  

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 13, Iss. 4, 2015-04 ,pp. : 665-670

John Wiley & Sons Inc

Access to resources Recommend Favorite

Distinguishing between anti–platelet factor 4/heparin antibodies that can and cannot cause heparin‐induced thrombocytopenia

By  

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 1538-7933, Iss. 10, 2015-10 ,pp. : 1900-1907

John Wiley & Sons Inc

Access to resources Recommend Favorite

Comparison between Fondaparinux and Low-Molecular-Weight Heparin in Patients with Acute Coronary Syndrome: A Meta-Analysis

By  

Cardiology, Vol. 133, Iss. 3, 2016-0 ,pp. : 163-172

Karger

Access to resources Recommend Favorite